SCHEMBL30007902

SCHEMBL30007902

CC(C)S(=O)(=O)c1ccc(-c2cnc3[nH]nc(C(=O)O)c3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSK3A P49840 4/20 0.46
GSK3B P49841 4/20 0.46
PRKAG1 P54619 2/20 0.41
PRKAA1 Q13131 2/20 0.41
PRKAB1 Q9Y478 2/20 0.41
PRKDC P78527 1/20 0.41
ATM Q13315 1/20 0.41
ATR Q13535 1/20 0.41
CAMKK2 Q96RR4 5/20 0.39
SGK1 O00141 3/20 0.39
AXL P30530 2/20 0.37
DYRK1A Q13627 2/20 0.36
DYRK1B Q9Y463 1/20 0.36
PRKAB2 O43741 1/20 0.36
PRKAA2 P54646 1/20 0.36
PRKAG3 Q9UGI9 1/20 0.36
PRKAG2 Q9UGJ0 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30007692 0.87 GSK3A (0.51) GSK3AGSK3BPRKAG1PRKAA1PRKAB1
SCHEMBL30007830 0.84 DYRK1A (0.45) GSK3AGSK3BPRKDCATMATR
SCHEMBL29253947 0.81 GSK3A (0.48) GSK3AGSK3BPRKDCATMATR
SCHEMBL30007738 0.79 KDM5A (0.42) GSK3AGSK3BPRKAG1PRKAA1PRKAB1
Hydrochloric Acid SCHEMBL30007576 0.79 AXL (0.54) CAMKK2SGK1AXLDYRK1A
SCHEMBL29253946 0.78 GSK3B (0.46) GSK3AGSK3BDYRK1A
SCHEMBL29253944 0.78 GSK3B (0.46) GSK3AGSK3BDYRK1A
SCHEMBL30912725 0.78 GSK3B (0.46) GSK3AGSK3BDYRK1A
SCHEMBL30912733 0.78 GSK3B (0.46) GSK3AGSK3BDYRK1A
SCHEMBL30007248 0.77 ATR (0.40) GSK3BATRDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO disclosed